Clinical trial
Fenofibrate in Dyslipidemia and Metformin-Controlled Diabetes
NCT00349128 · Solvay Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00349128 |
|---|---|
| Title | Fenofibrate in Dyslipidemia and Metformin-Controlled Diabetes |
| Official title | A Randomized, Double-Blind Trial Assessing the Efficacy and Safety of Low and Standard Doses of Fenofibrate in Combination With Metformin on the Lipid Profile in Patients With Type 2 Diabetes and Dyslipidemia. |
| Lead sponsor | Solvay Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Dyslipidemia/Glucose Metabolism Disorder |
| Intervention type | Drug |
| Interventions | fenofibrate and metformin combination (drug) |
| Enrollment | 382 |
| Start date | Jan 1, 2004 |
| First posted | Jul 6, 2006 |
| Last update posted | Sep 3, 2007 |
| Countries | Poland, Ukraine, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: